Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

SELL
$26.13 - $33.94 $9,537 - $12,388
-365 Reduced 4.43%
7,879 $226,000
Q3 2023

Oct 19, 2023

BUY
$32.09 - $37.51 $7,958 - $9,302
248 Added 3.1%
8,244 $273,000
Q2 2023

Jul 17, 2023

SELL
$36.12 - $41.79 $50,423 - $58,338
-1,396 Reduced 14.86%
7,996 $293,000
Q1 2023

May 04, 2023

SELL
$39.39 - $51.28 $552,365 - $719,099
-14,023 Reduced 59.89%
9,392 $383,000
Q4 2022

Feb 01, 2023

SELL
$41.75 - $54.5 $169,045 - $220,670
-4,049 Reduced 14.74%
23,415 $1.2 Million
Q3 2022

Oct 24, 2022

BUY
$43.76 - $53.42 $58,157 - $70,995
1,329 Added 5.09%
27,464 $1.2 Million
Q2 2022

Jul 26, 2022

BUY
$46.53 - $55.17 $94,642 - $112,215
2,034 Added 8.44%
26,135 $1.37 Million
Q1 2022

May 05, 2022

BUY
$45.75 - $56.69 $395,920 - $490,595
8,654 Added 56.02%
24,101 $1.25 Million
Q4 2021

Jan 26, 2022

SELL
$41.32 - $61.25 $49,170 - $72,887
-1,190 Reduced 7.15%
15,447 $912,000
Q3 2021

Oct 21, 2021

BUY
$39.25 - $50.42 $189,381 - $243,276
4,825 Added 40.85%
16,637 $715,000
Q2 2021

Jul 26, 2021

SELL
$35.91 - $40.68 $36,807 - $41,697
-1,025 Reduced 7.98%
11,812 $462,000
Q1 2021

May 04, 2021

SELL
$33.49 - $37.77 $602 - $679
-18 Reduced 0.14%
12,837 $465,000
Q4 2020

Jan 26, 2021

SELL
$33.47 - $42.56 $31,495 - $40,048
-941 Reduced 6.82%
12,855 $473,000
Q3 2020

Oct 19, 2020

SELL
$31.75 - $37.25 $22,352 - $26,224
-704 Reduced 4.86%
13,796 $506,000
Q2 2020

Aug 04, 2020

SELL
$30.12 - $36.54 $967,424 - $1.17 Million
-32,119 Reduced 68.9%
14,500 $474,000
Q1 2020

May 01, 2020

SELL
$27.03 - $38.62 $54,087 - $77,278
-2,001 Reduced 4.12%
46,619 $1.52 Million
Q4 2019

Feb 07, 2020

BUY
$32.92 - $37.36 $1.6 Million - $1.82 Million
48,620 New
48,620 $1.9 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Great Diamond Partners, LLC Portfolio

Follow Great Diamond Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Diamond Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Diamond Partners, LLC with notifications on news.